Let's all guess what catalyst will bring money in
Post# of 30028
Posted On: 11/22/2014 10:41:05 PM
Let's all guess what catalyst will bring money in for the trials about to kick off, Amarantus is not selling LymPro in the near future!
Following the in-depth analysis of the full 140-subject mild-to-severe AD cohort, Amarantus will then make a determination regarding which version of LymPro (Version 1 or Version 2) to launch under the CLIA designation for marketing to the broader medical community in the United States in 2015.
Following the in-depth analysis of the full 140-subject mild-to-severe AD cohort, Amarantus will then make a determination regarding which version of LymPro (Version 1 or Version 2) to launch under the CLIA designation for marketing to the broader medical community in the United States in 2015.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼